Peter Simons covers a paper arguing that “psychology is fundamentally incompatible with hypothesis-driven theoretical science,” another paper finding that evidence-based medicine is more corporate gimmick than reliable science, a study that found psychiatrists deliver the worst-quality healthcare of any medical specialty, and more!
Hospitalized COVID patients over 65 were three times as likely to receive a dementia diagnosis if they took psychiatric drugs.
In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.
A new study finds that anticholinergic drugs, like antidepressants and antipsychotics, are associated with mild cognitive decline.
People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.
Study finds that elderly patients taking at least 5 medications were at increased risk of mild cognitive impairment and dementia.
A new study has found that the three most commonly-used dementia screening measures often misdiagnose patients.
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.
A partnership designed to decrease antipsychotic use in elderly patients may have led to increased use of medications with even worse risk/benefit profiles.
Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.
Therapists can use music to meet the emotional and social needs of individuals with dementia.
From Healio: Researchers recently found that veterans diagnosed with PTSD and prescribed antidepressants or atypical antipsychotics are at a higher risk for dementia than veterans...
A new study published in JAMA Internal Medicine, the largest study of its kind, has shown it is possible to reduce the use of antipsychotics in nursing homes, by engaging their staff in a training program designed to target residents’ strengths and their unmet needs.
Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.
BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics
Research reveals that rates of antipsychotic prescribing to the elderly in the UK have not dropped despite national recommendations.
For STAT, Judith Graham tells the story of her sister who had always strongly opposed aggressive life-sustaining measures for herself until she developed dementia....
The percentage of seniors in the United States prescribed potentially deadly antipsychotic drugs increases with age. A new study reveals that in the face of serious risks of strokes, fractures, kidney injuries, and death, over seventy-five percent of seniors given antipsychotics do not have a diagnosis for a mental disorder.
Huffington Post and journalist Steve Brill have combined to launch a 15 part series about how Johnson & Johnson illegally violated FDA restrictions by pushing the antipsychotic drug, Risperdal, for use with adolescents and the elderly. The series, entitled “America’s Most Admired Lawbreaker,” launched yesterday and will include mixed media, videos, podcasts, source documents, as well as 15 written chapters. Click more for a synopsis of part 1.
Right now in Britain there is a controversy shaping up between the commercial and financial interests of big managed-care corporations and the need to care for vulnerable people in the community, people with conditions like dementia and long-term psychoses. Conflicts of interest are nothing new in the contested field of mental health, but this one threatens not only quality of care, but the well-being of low paid workers, mainly women, who are employed as support workers.